• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Anlotinib Market Research Report 2024(Status and Outlook)

Global Anlotinib Market Research Report 2024(Status and Outlook)

  • Category:Life Sciences
  • Published on : 02 October 2024
  • Pages :91
  • Formats:
  • Report Code:24MRES-8010069
Click for best price

Best Price: $2600

The global Anlotinib market size was valued at US$ 287.4 million in 2024 and is projected to reach US$ 512.6 million by 2030, at a CAGR of 10.1% during the forecast period 2024-2030.

United States Anlotinib market size was valued at US$ 18.6 million in 2024 and is projected to reach US$ 37.2 million by 2030, at a CAGR of 12.3% during the forecast period 2024-2030.

fallback
Anlotinib is a multi-target tyrosine kinase inhibitor used in the treatment of advanced non-small cell lung cancer and soft tissue sarcoma.

Rapid growth supported by increasing approvals in Asian markets. Limited availability in Western markets currently constraining global size. Potential for expanded indications and geographic reach driving future prospects.

Report Overview

This report provides a deep insight into the global Anlotinib market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anlotinib Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anlotinib market in any manner.
Global Anlotinib Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company

  • CHIA TAI TIANQING

Market Segmentation (by Type)
  • 8mg Capsules
  • 10mg Capsules
  • 12mg Capsules

Market Segmentation (by Application)
  • Non-small Cell Lung Cancer
  • Ovarian Cancer
  • Soft Tissue Sarcoma
  • Other

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Anlotinib Market
  • Overview of the regional outlook of the Anlotinib Market:

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Anlotinib
1.2 Key Market Segments
1.2.1 Anlotinib Segment by Type
1.2.2 Anlotinib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Anlotinib Market Overview
2.1 Global Market Overview
2.1.1 Global Anlotinib Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anlotinib Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Anlotinib Market Competitive Landscape
3.1 Global Anlotinib Sales by Manufacturers (2019-2024)
3.2 Global Anlotinib Revenue Market Share by Manufacturers (2019-2024)
3.3 Anlotinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anlotinib Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anlotinib Sales Sites, Area Served, Product Type
3.6 Anlotinib Market Competitive Situation and Trends
3.6.1 Anlotinib Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anlotinib Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Anlotinib Industry Chain Analysis
4.1 Anlotinib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Anlotinib Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Anlotinib Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anlotinib Sales Market Share by Type (2019-2024)
6.3 Global Anlotinib Market Size Market Share by Type (2019-2024)
6.4 Global Anlotinib Price by Type (2019-2024)
7 Anlotinib Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anlotinib Market Sales by Application (2019-2024)
7.3 Global Anlotinib Market Size (M USD) by Application (2019-2024)
7.4 Global Anlotinib Sales Growth Rate by Application (2019-2024)
8 Anlotinib Market Segmentation by Region
8.1 Global Anlotinib Sales by Region
8.1.1 Global Anlotinib Sales by Region
8.1.2 Global Anlotinib Sales Market Share by Region
8.2 North America
8.2.1 North America Anlotinib Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anlotinib Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anlotinib Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anlotinib Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anlotinib Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 CHIA TAI TIANQING
9.1.1 CHIA TAI TIANQING Anlotinib Basic Information
9.1.2 CHIA TAI TIANQING Anlotinib Product Overview
9.1.3 CHIA TAI TIANQING Anlotinib Product Market Performance
9.1.4 CHIA TAI TIANQING Business Overview
9.1.5 CHIA TAI TIANQING Anlotinib SWOT Analysis
9.1.6 CHIA TAI TIANQING Recent Developments
10 Anlotinib Market Forecast by Region
10.1 Global Anlotinib Market Size Forecast
10.2 Global Anlotinib Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anlotinib Market Size Forecast by Country
10.2.3 Asia Pacific Anlotinib Market Size Forecast by Region
10.2.4 South America Anlotinib Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anlotinib by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Anlotinib Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anlotinib by Type (2025-2030)
11.1.2 Global Anlotinib Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anlotinib by Type (2025-2030)
11.2 Global Anlotinib Market Forecast by Application (2025-2030)
11.2.1 Global Anlotinib Sales (Kilotons) Forecast by Application
11.2.2 Global Anlotinib Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anlotinib Market Size Comparison by Region (M USD)
Table 5. Global Anlotinib Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Anlotinib Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anlotinib Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anlotinib Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anlotinib as of 2022)
Table 10. Global Market Anlotinib Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anlotinib Sales Sites and Area Served
Table 12. Manufacturers Anlotinib Product Type
Table 13. Global Anlotinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anlotinib
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anlotinib Market Challenges
Table 22. Global Anlotinib Sales by Type (Kilotons)
Table 23. Global Anlotinib Market Size by Type (M USD)
Table 24. Global Anlotinib Sales (Kilotons) by Type (2019-2024)
Table 25. Global Anlotinib Sales Market Share by Type (2019-2024)
Table 26. Global Anlotinib Market Size (M USD) by Type (2019-2024)
Table 27. Global Anlotinib Market Size Share by Type (2019-2024)
Table 28. Global Anlotinib Price (USD/Ton) by Type (2019-2024)
Table 29. Global Anlotinib Sales (Kilotons) by Application
Table 30. Global Anlotinib Market Size by Application
Table 31. Global Anlotinib Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Anlotinib Sales Market Share by Application (2019-2024)
Table 33. Global Anlotinib Sales by Application (2019-2024) & (M USD)
Table 34. Global Anlotinib Market Share by Application (2019-2024)
Table 35. Global Anlotinib Sales Growth Rate by Application (2019-2024)
Table 36. Global Anlotinib Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Anlotinib Sales Market Share by Region (2019-2024)
Table 38. North America Anlotinib Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Anlotinib Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Anlotinib Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Anlotinib Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Anlotinib Sales by Region (2019-2024) & (Kilotons)
Table 43. CHIA TAI TIANQING Anlotinib Basic Information
Table 44. CHIA TAI TIANQING Anlotinib Product Overview
Table 45. CHIA TAI TIANQING Anlotinib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CHIA TAI TIANQING Business Overview
Table 47. CHIA TAI TIANQING Anlotinib SWOT Analysis
Table 48. CHIA TAI TIANQING Recent Developments
Table 49. Global Anlotinib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 50. Global Anlotinib Market Size Forecast by Region (2025-2030) & (M USD)
Table 51. North America Anlotinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 52. North America Anlotinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 53. Europe Anlotinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 54. Europe Anlotinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 55. Asia Pacific Anlotinib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Asia Pacific Anlotinib Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. South America Anlotinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. South America Anlotinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Middle East and Africa Anlotinib Consumption Forecast by Country (2025-2030) & (Units)
Table 60. Middle East and Africa Anlotinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Global Anlotinib Sales Forecast by Type (2025-2030) & (Kilotons)
Table 62. Global Anlotinib Market Size Forecast by Type (2025-2030) & (M USD)
Table 63. Global Anlotinib Price Forecast by Type (2025-2030) & (USD/Ton)
Table 64. Global Anlotinib Sales (Kilotons) Forecast by Application (2025-2030)
Table 65. Global Anlotinib Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Anlotinib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anlotinib Market Size (M USD), 2019-2030
Figure 5. Global Anlotinib Market Size (M USD) (2019-2030)
Figure 6. Global Anlotinib Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anlotinib Market Size by Country (M USD)
Figure 11. Anlotinib Sales Share by Manufacturers in 2023
Figure 12. Global Anlotinib Revenue Share by Manufacturers in 2023
Figure 13. Anlotinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anlotinib Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anlotinib Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anlotinib Market Share by Type
Figure 18. Sales Market Share of Anlotinib by Type (2019-2024)
Figure 19. Sales Market Share of Anlotinib by Type in 2023
Figure 20. Market Size Share of Anlotinib by Type (2019-2024)
Figure 21. Market Size Market Share of Anlotinib by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anlotinib Market Share by Application
Figure 24. Global Anlotinib Sales Market Share by Application (2019-2024)
Figure 25. Global Anlotinib Sales Market Share by Application in 2023
Figure 26. Global Anlotinib Market Share by Application (2019-2024)
Figure 27. Global Anlotinib Market Share by Application in 2023
Figure 28. Global Anlotinib Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anlotinib Sales Market Share by Region (2019-2024)
Figure 30. North America Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Anlotinib Sales Market Share by Country in 2023
Figure 32. U.S. Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Anlotinib Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Anlotinib Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Anlotinib Sales Market Share by Country in 2023
Figure 37. Germany Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Anlotinib Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anlotinib Sales Market Share by Region in 2023
Figure 44. China Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Anlotinib Sales and Growth Rate (Kilotons)
Figure 50. South America Anlotinib Sales Market Share by Country in 2023
Figure 51. Brazil Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Anlotinib Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anlotinib Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Anlotinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Anlotinib Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anlotinib Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anlotinib Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anlotinib Market Share Forecast by Type (2025-2030)
Figure 65. Global Anlotinib Sales Forecast by Application (2025-2030)
Figure 66. Global Anlotinib Market Share Forecast by Application (2025-2030)

SELECT A FORMAT

USD GBP EURO YEN Single User License
USD GBP EURO YEN Multi User License
USD GBP EURO YEN Corporate User License

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount